TCW Group Inc. Sells 4,188 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

TCW Group Inc. lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 296,220 shares of the medical equipment provider’s stock after selling 4,188 shares during the quarter. Intuitive Surgical makes up 1.3% of TCW Group Inc.’s holdings, making the stock its 18th largest holding. TCW Group Inc.’s holdings in Intuitive Surgical were worth $145,524,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical during the second quarter valued at $26,000. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. LGT Financial Advisors LLC grew its stake in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter worth about $33,000. Finally, Mark Sheptoff Financial Planning LLC purchased a new position in shares of Intuitive Surgical during the second quarter worth approximately $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ISRG. Leerink Partners increased their price objective on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Finally, Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $541.33.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the sale, the insider now directly owns 295 shares of the company’s stock, valued at approximately $145,113.45. This represents a 87.76 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,485 shares of company stock valued at $26,128,102. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $538.09 on Wednesday. The stock’s fifty day moving average price is $517.16 and its 200 day moving average price is $475.65. Intuitive Surgical, Inc. has a 1-year low of $309.80 and a 1-year high of $556.23. The company has a market cap of $191.66 billion, a price-to-earnings ratio of 86.51, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.